Selection Guide,Patent

The field of nanopore technology has seen significant advancements, with a particular focus on protein-based nanopores for applications in sensing and sequencing. Among these, alpha-hemolysin (often abbreviated as a-HL or α-HL) has emerged as a principal component for the nanopore sequencing community. This article delves into the innovative realm of nanopore protein conjugates and uses thereof, with a specific emphasis on patents related to alpha-hemolysin and its diverse applications.

Alpha-hemolysin monomers, for example, have the remarkable ability to oligomerize and form a stable protein channel. This self-assembly property is a cornerstone of its utility in creating functional nanopores. The United States (US) patent landscape reveals a rich history of research and development in this area, with numerous PATENT filings detailing novel nanopore protein conjugate constructs and their uses thereof. These patents, such as US11150233B2, highlight the ongoing innovation in harnessing the unique properties of alpha-hemolysin for various technological breakthroughs.

The core of many of these patented innovations lies in the creation of nanopore protein conjugates. These conjugates often involve an alpha-hemolysin (a-HL) monomer or a carefully engineered variant thereof, which then forms the pore structure. The conjugate protein itself is designed to interact with specific analytes, enabling precise detection and analysis. For instance, research has explored the use of alpha hemolysin nanopores in conjunction with enzymes like phi29 DNA polymerase for enhanced DNA sequencing capabilities. This synergy between the hemolysin protein nanopore and other biomolecules demonstrates the versatility of these constructs.

The nanopore itself, formed by the oligomerization of alpha-hemolysin monomers, creates a confined channel through which molecules can pass. The precise dimensions and electrical properties of this channel can be modulated through protein engineering. Patents describe alpha-hemolysin variants designed to form narrower channels, such as those with specific amino acid substitutions like D127G and D128K relative to a reference sequence (SEQ ID NO: 1). These modifications aim to improve the resolution and specificity of nanopore sensing. Furthermore, long lifetime alpha-hemolysin nanopores are also a subject of patenting, with efforts focused on stabilizing the protein structure against degradation and improving the longevity of the nanopore device. Variants with substitutions at positions like H35G, E111N, M113A, and K147N in the mature protein are examples of such advancements.

Beyond sequencing, the applications of these nanopores are broad. They are being explored for sensing small molecules, nucleotides, and even larger biomolecules like proteins. The ability of alpha-HL to form a stable and well-characterized pore has made it a workhorse in the field. The term "uses thereof" in patent titles signifies the extensive exploration of these protein-based nanopores for practical devices and diagnostic tools. The nanopore field is continuously evolving, with ongoing research into new materials and methods for creating and utilizing these tiny channels.

The U.S. Patent system, along with other international patent offices, plays a crucial role in protecting the intellectual property surrounding these advancements. Numerous applications and granted Patents related to nanopore protein conjugates and their uses thereof are publicly available, offering a glimpse into the cutting-edge research being conducted. For example, US Patent Application Number 17539033 (from Encodia, Inc.) touches upon polypeptide terminal binders and their uses, indicating broader applications of protein engineering in biotechnology.

In summary, the landscape of nanopore protein conjugates and uses thereof, particularly those involving alpha-hemolysin, is a dynamic area of scientific and technological innovation. The detailed descriptions within PATENT documents, including U.S. Pat and U.S. Patent App filings, showcase the intricate engineering of protein structures like alpha-hemolysin to create highly sensitive and specific detection platforms. The ongoing exploration of applications for these nanopores promises to drive significant advancements in fields ranging from molecular diagnostics to next-generation sequencing.